Related Experiment Videos
HTLV-I Tax and cell cycle progression
1Laboratoire de Recombinaison et Expression Genetique, Institut Pasteur, Paris, France.
Progress in Cell Cycle Research
|March 31, 2000
Summary
Human T-cell leukemia virus type I (HTLV-I) Tax protein drives cancer by disrupting cell cycle control. It targets key regulators, promoting uncontrolled cell growth and DNA damage susceptibility.
Area of Science:
- Virology
- Molecular Biology
- Oncology
Background:
- Human T-cell leukemia virus type I (HTLV-I) causes adult T-cell leukemia (ATL) and neurological disorders.
- The HTLV-I Tax protein is an oncoprotein crucial for cellular transformation.
- Tax functions as a transcriptional activator, similar to other oncoproteins like Myc, Jun, and Fos.
Purpose of the Study:
- To elucidate the mechanisms by which the HTLV-I Tax protein dysregulates the cell cycle.
- To investigate Tax's interactions with cell cycle regulators at different phases (G1/S and M).
Main Methods:
- Analysis of Tax's interactions with cell cycle regulators.
- Investigating Tax's effects on G1/S phase progression.
- Examining Tax's impact on the M phase mitotic spindle checkpoint.
Main Results:
- Tax directly abrogates the inhibitory function of p16INK4a on G1-cyclin-dependent kinases (cdks).
- Tax directly modulates cyclin D-cdk activities via protein-protein interactions.
- Tax targets the HsMAD1 protein, a component of the mitotic spindle assembly checkpoint.
Conclusions:
- HTLV-I Tax protein employs multiple mechanisms to disrupt cell cycle control.
- Tax's interactions lead to dysregulated cellular growth and increased susceptibility to DNA damage.
- Understanding these mechanisms is vital for targeting HTLV-I-associated malignancies.